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PREFACE 
The Safe Drinking Water and Toxic Enforcement Act of 1986 (Proposition 
65, California Health and Safety Code 25249.5 et seq.) requires that the 
Governor cause to be published a list of those chemicals “known to the state” 
to cause cancer or reproductive toxicity.  The Act specifies that “a chemical 
is known to the state to cause cancer or reproductive toxicity...if in the 
opinion of the state’s qualified experts the chemical has been clearly shown 
through scientifically valid testing according to generally accepted principles 
to cause cancer or reproductive toxicity.”  The lead agency for implementing 
Proposition 65 is the Office of Environmental Health Hazard Assessment of 
the California Environmental Protection Agency.  The “state’s qualified 
experts” regarding findings of carcinogenicity are identified as the members 
of the Carcinogen Identification Committee of the OEHHA Science Advisory 
Board (22 CCR 12301). 
2,4,5-Trimethylaniline  was discussed as a high priority candidate for 
Committee review during a public committee meeting held in Sacramento, 
California, on July 22, 1996 and at a public workshop held November 15, 
1996.  Public input was solicited on the priority of this chemical in two public 
comment periods, each of 60 days duration.  Once the chemical was selected 
for Committee review, a public request for pertinent information was made. 
This draft document Evidence on the Carcinogenicity of 2,4,5­
Trimethylaniline and Its Strong Acid Salts was developed to provide the 
Committee with relevant information for use in its deliberations, and reviews 
the available scientific evidence on the carcinogenic potential of 2,4,5­
trimethylaniline  and its strong acid salts.  A public meeting of the Committee 
to discuss this evidence is tentatively scheduled for September 25, 1997. 
Written public comment on the document should be submitted to OEHHA by 
August 20, 1997, in order to be considered by the Committee in advance of 
the meeting.  During the September meeting, the public will have an 
opportunity to present verbal comments to the Committee. 
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1 EXECUTIVE  SUMMARY 
2,4,5-Trimethylaniline (CAS number 137-17-7) has been used as an 
intermediate for dye manufacture.  The hydrochloride (CAS number 21436­
97-5) and other strong acid salts are expected exist in a dissociated state in 
solution and in vivo, and thus are considered toxicologically equivalent to the 
free or protonated amine form.  2,4,5-Trimethylaniline has been demonstrated 
to induce liver carcinoma in male and female Fischer 344 rats and female 
B6C3F1  mice in studies by the National Cancer Institute (NCI).  In these 
studies liver carcinomas were also significantly elevated in male mice, but not 
to the same extent as for the female.  Significant increases in lung tumors 
were also observed in treated rats of both sexes and female mice.  Bile duct 
carcinoma, which rarely occurs spontaneously, was also observed in male 
rats, and a few tumors of this type were also noted in male mice; the results 
were statistically significant in the rat but not the mouse.  While it has been 
noted that the NCI test substance contained an unidentified impurity, gas-
liquid chromatography indicated a greater than 99.9% purity of 2,4,5­
trimethylaniline, and an impurity that could account for study findings has not 
been hypothesized. 
In a second series of studies using the hydrochloride (Weisburger et al., 
1978), the findings of statistically significant increases of liver tumors were 
repeated in HaM/ICR mice of both sexes.  In addition, lung tumors were 
observed to be significantly elevated in male and female mice. Male Charles 
River rats were also tested in this series, and significant dose-response was 
not observed.  Because of limitations in study reporting, the findings in mice 
for this second series are considered to provide supportive but not conclusive 
evidence of carcinogenicity. 
2,4,5-trimethylaniline is mutagenic in the Salmonella typhimurium with 
metabolic activation, cultured rat fibroblasts, and in vivo in Drosophila 
melanogaster. 
Based on the information reviewed in the preparation of this document, there 
is evidence for the carcinogenicity of 2,4,5-trimethylaniline and its strong 
acid salts at multiple sites in two species. Observations of genetic toxicity 
and chemical structural analogies with known carcinogens contribute to the 
weight of evidence. 
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2 INTRODUCTION 
2.1  Identity of 2,4,5-trimethylaniline 
NH2 
CH3 
H3C 
CH3 
2,4,5-Trimethylaniline:  C9H13N 
Molecular Weight = 135.2  CAS Registry No.  137-17-7 
Synonyms:	  1-amino-2,4,5-trimethylbenzene; psi-cumidine; pseudo­
cumidine; 1,2,4-trimethyl-5-aminobenzene 
2,4,5-Trimethylaniline Hydrochloride:  C9H13N.HCl 
Molecular Weight = 171.7  CAS Registry No. 21436-97-5 
Synonyms:	  1-amino-2,4,5-trimethylbenzene hydrochloride; psi-cumidine 
hydrochloride; pseudo-cumidine hydrochloride; 
1,2,4-trimethyl-5-aminobenzene hydrochloride 
NTP (1979) described 2,4,5-trimethylaniline (the free amine) as a fine gray-
white powder with a melting point of 64°C.  The hydrochloride has a melting 
point of 235°C (Weisburger et al., 1978). 
2.2  Occurrence and use 
2,4,5-Trimethylaniline is one of the structural isomers of trimethylaniline 
present in the amine mixture formerly manufactured in the US as an 
intermediate for the synthesis of the dye Ponceau 3R (C.I. Food Red 6; 
3-hydroxy-4-[(2,4,5-trimethylphenyl)azo]-2,7-naphthalenedisulphonic acid, 
disodium salt).  This mixture also contained methyl-, dimethyl- and 
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trimethylanilines, including 2,4,6-trimethylaniline. The hydrochloride (CAS 
number 21436-97-5) and other strong acid salts are expected to exist in 
dissociated in form in solution and in vivo, and thus are toxicologically 
equivalent to the free and protonated amine. 
Ponceau 3R dye was formerly used in foods and cosmetics, but approval of 
these uses has been canceled on the basis of animal toxicity studies (IARC, 
1975). It has also been used to dye wool.  No evidence of 2,4,5­
trimethylaniline manufacture in the US since the 1960s was found, but it is 
unclear whether it might be present in imported products, or as an 
environmental contaminant in areas of former manufacture or storage. 
3  DATA ON 2,4,5-TRIMETHYLANILINE CARCINOGENICITY 
Two series of carcinogenicity studies have been reported, in each of which 
the compound was administered in the diet to rats or mice. There are data 
indicating that 2,4,5-trimethylaniline has genetic toxicity: mutational effects in 
Salmonella, Drosophila and mammalian cells in culture have been reported. 
3.1  Epidemiological studies of carcinogenicity in humans. 
No data on long-term effects of human exposure to 2,4,5-trimethylaniline 
were found in an earlier search by the International Agency for Research on 
Cancer (IARC, 1982) or more recently by OEHHA. 
3.2  Carcinogenicity studies in animals. 
In two series of animal carcinogenicity studies (Weisburger et al., 1978; NCI, 
1979) both rats and mice received 2,4,5-trimethylaniline in the diet. A clear 
increase in liver tumors was observed in treated mice and rats of both sexes in 
one series (NCI, 1979), and in treated mice in the second series (Weisburger 
et al., 1978).  Tumors were also observed at sites other than the liver (in 
mice, lung and vascular tumors [NCI, 1979; Weisburger et al., 1978]; in rat 
lung [NCI, 1979] and subcutaneous fibromas and fibrosarcomas [Weisburger 
et al., 1978; marginally significant]). 
The NCI (1979) found as follows:  "It is concluded that under the conditions 
of this bioassay, 2,4,5-trimethylaniline was carcinogenic for male and female 
F344 rats and female B6C3F1  mice …"  On the other hand IARC (1982) 
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described the overall evidence of carcinogenicity in animals as limited.  The 
IARC reviewers did not state their reasons for this divergence of opinion with 
the NCI in detail, although they expressed concerns for the small control 
groups, the possibility of cross-contamination between this and other 
concurrent studies in the experimental suite, and purity of the test compound. 
The limitations of the design and reporting of the studies by NCI (1979) and 
Weisburger (1978) are described below, along with study findings.  No other 
studies have been reported. 
Rat Dietary Exposure:  NCI, 1979 
Groups of 50 male and 50 female Fischer 344 rats received 200 ppm or 800 
ppm 2,4,5-trimethylaniline (free amine) in the diet for 101 weeks.  Matched 
control groups for each sex, containing 20 animals, received plain diet.  Data 
from additional concurrent untreated groups of 20 animals of each sex, and 
historical and pooled control data were also reviewed. 
The design of this study, one of the early series conducted by NCI, is not 
consistent with the standard protocol used by National Toxicology Program. 
The matched control groups had 20 rather than 50 animals, and the test 
animals were housed in the same room as animals exposed to several other 
potentially carcinogenic test materials. Thus studies run under current 
protocol would have greater power than the NCI studies. 
NCI reported that gas chromatography (detector type not specified) indicated 
two components, one of which was > 99.9 %, and provided other identity 
data including mass spectrometric identification of the major component as 
2,4,5-trimethylaniline.  IARC (1982) on the other hand asserted that the 
purity of the test compound had not been established and noted the 
identification of at least one impurity. 
Hepatocellular carcinomas and neoplastic nodules, and lung adenomas and 
carcinomas were observed in both males and females.  Survival in control and 
exposed groups was close to 100% throughout most of the study, and was at 
or above 70% at study termination.  Tumor incidences in exposed and control 
animals are reported in detail in Table 1. The dose-related trend for liver 
tumors was significant (p < 0.001, Cochran-Armitage trend test) in both 
males and females, and for rare (Eustis et al., 1990) bile duct carcinoma in 
males  (p = 0.015, Cochran-Armitage trend test).  Incidences relative to 
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controls were significant (p < 0.01, Fisher Exact test) for liver tumors in high-
dose males and in females at both high and low doses. 
The incidence of lung tumors in high-dose females was also statistically 
significant (p < 0.01, Fisher Exact test).  Lung tumors were also elevated in 
treated males (p < 0.01, Cochran-Armitage trend test).  In addition, some 
bile-duct carcinomas were observed, in the high-dose male rats only, but the 
incidence was not statistically significant (p =  0.26, Fisher Exact test). 
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Table 1:  Tumors in Fischer 344 rats receiving 2,4,5-trimethylaniline, 
200 ppm or 800 ppm, in the diet for 101 weeks (NCI, 1979) 
Tumor Site and Type  Dose, ppm
a 
0  200  800 
Males 
1/19
b,d  3/50  11/50
h Liver  Neoplastic Nodules 
Hepatocellular 
Carcinomas 
0/19
d  3/50  11/50
h 
Bile-duct carcinoma  0/19
f  0/50  4/50 
All liver tumors  1/19
c  6/50  20/50
g 
Lung  Adenomas  0/20  0/49  5/50 
Carcinomas  1/20  0/49  2/50 
All lung tumors  1/20
e  0/49  7/50 
Females 
0/20
c  12/49
g  20/50
g Liver  Neoplastic Nodules 
Carcinomas  0/20
c  0/49  9/50
h 
Bile-duct carcinoma  0/19  0/49  1/50 
All liver tumors  0/20
c  12/49
g  27/50
g 
Lung  Adenomas  0/20  1/43  9/50
h 
Carcinomas  0/20  2/43  2/50 
All lung tumors  0/20
d  3/43  11/50
g 
a  Concentration of 2,4,5-trimethylaniline in feed
 
b  Number of lesion-bearing animals/total examined at 101 weeks.
 
c, d, e, f  Dose-related trend was significant by the Cochran-Armitage trend test 
(
c p < 0.001; 
d p < 0.005; 
e p < 0.01; 
h p = 0.015) 
g, h	  Incidence relative to control group was significant by the Fisher Exact 
test (
f p < 0.01; 
g p < 0.05) 
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 Rat (males only) Dietary Exposure:  Weisburger et al., 1978 
Groups of 25 male CD rats (from Charles River, Sprague-Dawley derived) 
received 1000 ppm or 2000 ppm 2,4,5-trimethylaniline (as the hydrochloride) 
in the diet for 78 weeks, with a further observation period of 26 weeks on 
plain diet.  A matched control group, containing 22 animals, received plain 
diet; pooled (111 animals) control data were also reviewed. A complete gross 
necropsy was performed an all animals dying after six months on the diet, or 
at the termination of the experiment. 
Incidences of subcutaneous fibromas and fibrosarcomas, and of liver tumors, 
were elevated in the low-dose group, but these results were statistically 
significant only relative to a pooled control group.  Tumor incidences in the 
matched controls, pooled controls, and exposed dose groups are reported in 
Table 2.  Only results of significance or interest to Weisburger et al. (1978) 
were included in the journal publication of this study 
Table 2:  Tumors in male CD rats receiving 2,4,5-trimethylaniline 
hydrochloride, 1000 ppm or 2000 ppm, in the diet for 78 weeks (Weisburger 
et al., 1978) 
Tumor Site and Type  Dose, ppm
a 
0 (matched)  0 (pooled)  1000  2000 
Liver tumors  2/22
b  2/111  3/17
c  2/25 
Subcutaneous fibromas 
and fibrosarcomas 
4/22  18/111  6/17
c  1/25 
a 
Concentration of 2,4,5-trimethylaniline in feed
b 
Number of lesion-bearing animals/total examined at 101 weeks. 
Incidence relative to pooled control group was significant (p < 0.025, 
Fisher Exact test). 
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Mouse Dietary Exposure: NCI, 1979 
Groups of 50 male and 50 female B6C3F1 mice received 50 ppm or 100 ppm 
2,4,5-trimethylaniline (as free amine) in the diet for 101 weeks.  Matched 
control groups for each sex, containing 20 animals, received plain diet.  Data 
from concurrent untreated groups of 20 animals of each sex, and historical 
and pooled control data were also reviewed. 
The design of this study, one of the early series conducted by NCI, is not 
consistent with the standard protocol used by National Toxicology Program. 
The matched control groups had 20 rather than 50 animals, and the test 
animals were housed in the same room as animals exposed to several other 
potentially carcinogenic test materials. Thus, studies run under the current 
NTP protocol would have greater power than the older NCI studies. 
NCI reported that gas chromatography indicated two components, one of 
which was > 99.9 %, and provided other identity data including mass 
spectrometric identification of the major component as 2,4,5-trimethylaniline. 
IARC (1982) on the other hand asserted that the purity of the test compound 
had not been established and noted the identification of at least one impurity. 
At the end of the study, hepatocellular carcinomas were observed in both 
male and female mice. The incidences of hyperplastic nodules were also 
somewhat elevated in the high-dose group in both sexes.  Incidences of lung 
tumors, and hemangiosarcomas (mostly in lymph nodes, but also at various 
other sites) were also marginally increased (0.05 < p < 0.12) in female mice. 
A few tumors of the biliary system (bile duct, gall bladder) were also 
observed in male mice.  Tumor incidences are reported in detail in Table 3. 
In female mice, the dose-related trends for hepatocellular carcinoma and for 
all liver tumors were significant (p < 0.001, Cochran-Armitage trend test), 
and incidences relative to controls were significant (p < 0.01, Fisher Exact 
test) at both high and low doses. In males incidences, of liver tumors were 
elevated in both dose groups, but the statistical significance was lower (p < 
0.05, Fisher Exact; p = 0.035, Cochran Armitage trend test). The incidence of 
liver tumors in males of this strain of mice is high and variable in historical 
data.  Because of this, and the possible applicability of the Bonferroni 
correction for multiple observations, NCI was unwilling to conclude that the 
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Table 3:  Tumors in B6C3F1 mice receiving 2,4,5-trimethylaniline, 
50 ppm or 100 ppm, in the diet for 101 weeks (NCI, 1979) 
Tumor Site and Type  Dose, ppm
a 
0  50  100 
Males 
1/20
b  3/50  7/50 Liver  Hyperplastic nodule 
Hepatocellular 
carcinoma 
5/20
d  26/50
f  27/50
f 
Bile duct carcinoma  0/20  2/50  2/50 
Gall bladder carcinoma  0/20  1/50  0/50 
All liver tumors  5/20
d  27/50
f  27/50
f 
Females 
0/20  4/49  13/50 Liver  Hyperplastic nodule 
Hepatocellular 
carcinoma 
0/20
c  18/49
e  40/50
e 
All liver tumors  0/20  18/49
e  40/50
e 
Lung  Carcinoma  0/19  4/49  6/48
g 
Adenoma  0/19  1/49  0/48 
All lung tumors  0/19  5/49  6/48
g 
Vascula­
ture 
Hemangiosarcoma  1/20  11/49
g  7/50 
a	  Concentration of 2,4,5-trimethylaniline in feed 
b	  Number of lesion-bearing animals/total examined at 101 weeks 
c, d	  Dose-related trend was significant by the Cochran-Armitage trend test 
(
c P < 0.001; 
d P < 0.05) 
e-g	  Incidence relative to control group (p values by the Fisher Exact test: 
e 
< 0.01; 
f < 0.05; 
g 0.05 < p < 0.12) 
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Table 4:  Tumors in CD-1 mice receiving 2,4,5-trimethylaniline 
hydrochloride, 1000 ppm or 2000 ppm in the diet, for 78 weeks 
(Weisburger  et al., 1978). 
Tumor Site and Type  Dose, ppm
a 
0 (matched)  0 (pooled)  1000  2000 
Males 
Liver tumors  3/18
b  7/99  9/14
c  19/21
c 
Lung tumors  5/18  24/99  11/14
c  10/21
d 
Vascular tumors  0/18  5/99  3/14  3/21 
“Multiple tumors”  6/18  14/99  9/14
d  14/21
d 
Females 
Liver tumors  0/20  1/102  6/15
c  14/22
c 
Lung tumors  6/20  32/102  11/15
c  12/22
d 
Vascular tumors  0/20  9/102  3/15  3/22 
“Multiple tumors”  6/20  21/102  9/15
d  12/22
d 
a	  Concentration of  2,4,5-trimethylaniline in feed 
b	  Number of lesion-bearing animals/total examined at 91 weeks 
Incidence  was  significant relative to both pooled and concurrent 
control groups (p < 0.025, Fisher Exact test) 
d	  Incidence relative to pooled control group was significant (p < 0.05, 
Fisher Exact test) 
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Mouse Dietary Exposure: Weisburger et al., 1978 
Groups of 25 male and 25 female CD-1 mice (from Charles River, random 
bred and derived from HaM/ICR strain) received 1000 ppm or 2000 ppm 
2,4,5-trimethylaniline (as the hydrochloride) in the diet for 78 weeks, with a 
further observation period of 13 weeks on plain diet.  Matched control groups 
for each sex, containing 20 animals, received plain diet; historical and pooled 
(100 animals) control data were also reviewed. 
The reported tumor incidences are shown in detail in Table 4.  Liver tumors 
(hepatomas) and lung tumors were observed in both males and females. 
Incidences of these tumors in all exposed groups were statistically significant 
relative to a pooled control group, and also (except in the case of lung tumors 
in both sexes in the high-dose groups) relative to the corresponding 
concurrent control group.  There was also an increase in the numbers of 
vascular tumors but this was not statistically significant.  The authors also 
reported an increase in animals with multiple tumors, which was statistically 
significant relative to pooled controls.  This classification apparently included 
subcutaneous fibromas or fibrosarcomas, but they did not report the actual 
incidences of these tumors.  Survival was poor in both sexes.  The IARC 
(1982) Working Group noted “that the poor survival and the scant detail in 
the reporting make evaluation of the study difficult.” 
3.3  Other relevant data 
In addition to the reported animal bioassays, additional evidence related to 
the possible carcinogenicity of 2,4,5-trimethylaniline is available.  This 
includes studies of genetic toxicity, observations of the pharmacokinetics and 
metabolism,  and structure-activity comparisons. 
3.3.1 Genetic Toxicology 
2,4,5-Trimethylaniline was found to be mutagenic in the Salmonella reverse 
mutation  assay with metabolic activation by Aroclor-induced rat liver 
enzymes (Zimmer et al., 1980; Kugler-Steigmeier et al., 1989).  2,4,5­
trimethylaniline did not induce strand breaks in the DNA of Chinese hamster 
V79 cells in vitro (Zimmer et al., 1980).  Kugler-Steigmeier et al. (1989) 
observed mutations with this compound in a 6-thioguanine resistance test in 
primary cultured rat fibroblasts; the toxicity of the compound at higher doses 
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interfered with the observation of a dose response curve, and maximum 
response was observed at the second lowest concentration (148 µg/ml 
medium)  studied.  The latter authors also observed a positive response with 
2,4,5-trimethylaniline in a somatic mutation and recombination test in vivo in 
Drosophila melanogaster. 
The data now available on genotoxicity of 2,4,5-trimethylaniline are more 
extensive than those available to NCI and IARC in their earlier evaluations. 
No genotoxicity studies were reviewed by NCI (1979), and only the study by 
Zimmer et al. (1980) was reviewed by IARC (1982). 
3.3.2 Structure-Activity Comparisons 
The dye Ponceau 3R, which was made from trimethylaniline mixtures, was 
identified as a liver carcinogen and its registrations for food and cosmetic 
uses were withdrawn.  Ponceau 3R is cleaved metabolically in vivo to 1­
amino-2-naphthol-3,6-disulfonic acid and trimethylanilines (including 2,4,5­
trimethylaniline).  The carcinogenic effect of the dye has been attributed to 
the trimethylanilines (NCI, 1979; Lindstrom et al., 1969). 
The isomeric compound 2,4,6-trimethylaniline was studied in the series of 
carcinogenicity bioassays by Weisburger et al. (1978) and induced tumors in 
all three test systems (male rat, male and female mouse), although this 
evidence  was considered inadequate by IARC (1982).  2,4,6-trimethylaniline 
is mutagenic in Salmonella, fibroblasts and Drosophila (Kugler-Steigmeier et 
al., 1989), and induces DNA repair in rat hepatocytes (Yoshimi et al., 1988). 
There is a considerable literature documenting carcinogenicity and 
mutagenicity of aromatic amines in general, and substituted anilines in 
particular.  The structure-activity prediction program Oncologic, which is 
based on a set of rules generated by US EPA experts from data on known 
carcinogens, indicated a “High-Moderate” concern for carcinogenicity to 
2,4,5-trimethylaniline, which is the highest level found for agents which do 
not actually appear in the program’s source database of known carcinogens. 
3.3.3 Pharmacokinetics and Metabolism 
No studies of pharmacokinetics or metabolism of 2,4,5-trimethylaniline were 
identified in the literature.  However, the role of metabolic activation in the 
genotoxicity and carcinogenicity of other aromatic amines is well established. 
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Kugler-Steigmeier  et al. (1989) discussed the interpretation of their test 
results on the basis of a role for metabolic activation. They described the 
dependence of the result in Salmonella on activation by rat liver enzymes, 
and possible metabolic influences on the timing of observable effects in the 6­
thioguanine resistance test.  They also noted that the result seen in the 
somatic mutation test in Drosophila, which consisted of small wing spots 
only, resulted from a late action in the exposed larva.  This was explained as 
the result of age dependent increases in the levels of activating enzymes. 
3.3.4 Pathology 
The tumors observed in both studies in rat and mouse liver were considered 
by the authors (Weisburger et al., 1978; NCI, 1979)  to meet standard criteria 
for hepatocellular adenomas and carcinomas.  It is generally considered that 
these tumor phenotypes are related in origin, and that the adenomas may 
progress to carcinomas. They are therefore usually aggregated for carcinogen 
identification and risk assessment purposes.  Weisburger et al. (1978) 
illustrated a metastatic hepatocellular carcinoma in the lung of a female 
mouse given 2,4,5-trimethylaniline. Tumors at other sites, including the 
mouse lung, were also diagnosed as carcinomas. 
3.4 Mechanism 
Based on several results in tests in vivo and in vitro, 2,4,5-trimethylaniline 
appears to be genotoxic, probably after metabolic activation.  A genotoxic 
mechanism may therefore be responsible for the observed carcinogenic effect. 
Other aromatic amines which have been more extensively studied than 2,4,5­
trimethylaniline are known to cause cancer by this mechanism. 
The positive carcinogenicity findings in rat and mouse liver, associated with 
positive results at other sites and with indications of genotoxic potential, are 
interpreted as an indication of general, rather than species- or tissue-specific 
activity (Haseman et al., 1993; Gold et al., 1991; Huff et al., 1991). 
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4  SUMMARY AND CONCLUSIONS 
4.1  Summary of evidence 
2,4,5-Trimethylaniline has been demonstrated to induce liver carcinoma in 
male and female Fischer 344 rats and female B6C3F1 mice in studies by the 
National Cancer Institute (NCI).  In these studies liver carcinomas were also 
significantly elevated in male mice, but not to the same extent as for the 
female.  Significant increases in lung tumors were also observed in treated 
rats of both sexes and female mice.  The incidence of bile duct carcinoma, 
which rarely occurs spontaneously, was also observed in male rats, and a few 
tumors of this type were also observed in male mice; the result statistically 
significant in the rat but not the mouse. 
With regard to study deficiencies, the noted limitations size of control group 
and animal housing for the NCI studies would limit the study’s power to 
detect effect, rather than result in spurious findings of positive effect. 
Regarding purity of the NCI test substance, although a second 
chromatographic peak was reported, the test substance was more than 99.9% 
pure, and no contaminant was hypothesized to be present at levels of < 0.1% 
which might otherwise explain the study results. 
In a second series of studies using 2,4,5-trimethylaniline hydrochloride 
(Weisburger  et al., 1978), findings of statistically significant increases of liver 
tumors were also seen in HaM/ICR mice of both sexes.  In addition, lung 
tumors were observed significantly elevated in male and female mice. Tumors 
were not observed their study in male Charles River rats.  Because of 
limitations in study reporting, the positive findings in mice for this second 
series are considered to provide supportive but not conclusive evidence of 
carcinogenicity.  This (Weisburger et al.) study was undertaken by NCI as 
part of a large scale initiative to identify industrial carcinogens used as 
intermediates in manufacturing, and journal publication of study results for 
2,4,5-trimethylaniline and a number of other agents was limited to findings of 
significance or interest.  The studies were conducted according to well 
reviewed protocols.  While limited in power to detect effects because of small 
numbers of animals in control and treatment groups, the study provides 
information useful in evaluating the overall weight of evidence. 
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2,4,5-trimethylaniline is mutagenic in the Salmonella typhimurium with 
metabolic activation, cultured rat fibroblasts, and in vivo in Drosophila 
melanogaster. These findings of mutagenicity and similar structure-activity 
relationships to other carcinogenic aromatic amines add to the overall weight 
of evidence for carcinogenicity. 
4.2  Conclusion 
Based on the information reviewed in the preparation of this document, there 
is evidence for the carcinogenicity of 2,4,5-trimethylaniline and its strong 
acid salts at multiple sites in two species. Observations of genetic toxicity 
and chemical structural analogies with known carcinogens contribute to the 
weight of evidence. 
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